Browsing by Author "Salvado, Gemma"

Brain structural alterations in cognitively unimpaired individuals with discordant amyloid-ß PET and CSF Aß42 status: findings using machine learning

Cumplido Mayoral, Irene; Shekari, Mahnaz; Salvado, Gemma; Operto, Grégory; Cacciaglia, Raffaele; Falcón, Carles; Niñerola Baizán, Aida; Perissinotti, Andrés; Minguillón, Carolina; Vilaplana Besler, Verónica (Wiley, 2021-12)
Article
Open Access

Background: CSF Aß42 is thought to show AD-related alterations earlier than amyloid-ß PET. Therefore, cognitively unimpaired (CU) individuals with abnormal CSF Aß42 and normal amyloid-ß PET are believed to be in the ...

Characteristic brain volumetric changes in the AD preclinical signature

Petrone, Paula; Casamitjana Díaz, Adrià; Falcón, Carlos; Artigues, Miquel; Operto, Grégory; Skouras, Stavros; Cacciaglia, Raffaele; Molinuevo, Jose Luis; Vilaplana Besler, Verónica; Gispert, Juan Domingo; Salvado, Gemma (Elsevier, 2018)
Article
Open Access

Machine learning on combined neuroimaging and plasma biomarkers for triaging participants of secondary prevention trials in Alzheimer’s disease

Cumplido Mayoral, Irene; Salvado, Gemma; Shekari, Mahnaz; Operto, Grégory; Falcón, Carles; Milà Alomà, Marta; Niñerola Baizán, Aida; Molinuevo Guix, José Luis; Zetterberg, Henrik; Blennow, Kaj; Suarez-Calvet, Marc; Vilaplana Besler, Verónica; Gispert López, Juan Domingo (Wiley, 2021-12)
Article
Open Access

Background: Plasma biomarkers have demonstrated excellent agreement with established markers of amyloid-ß (Aß) positivity (PET and CSF) to identify patients with symptomatic AD. However, their predictive capacity in ...

UPCommons. Global access to UPC knowledge